Alantra Partners S.A. (ALNT)
Madrid Exchange · Spain · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 8.760 |
|---|---|
| 52-week range | 7.880 – 11.250 |
| Return, 1 month / 3 months | −6.2% / −13.7% |
| Return, 1 year / 3 years | +7.3% / +4.4% |
| Trend | Below its 200-day average |
| RSI (14) | 25 |
| Volatility (1 year) | 20.5% |
| Worst drawdown (1 year) | -17.3% |
| Average daily value traded | 0.14M EUR |
| Dividend yield | 4.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alantra Partners is a financial services firm based in Spain. It provides investment banking advice, helping companies with mergers, acquisitions and raising capital, and it also runs asset management activities through investment funds and vehicles. Its clients include businesses, institutional investors and financial sponsors, and it operates across Europe and other international markets. The firm combines advisory work with fund management, serving mid-market companies and investors seeking specialist financial expertise.
Alantra Partners S.A. trades under the code ALNT on the Madrid Exchange in Spain, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alantra Partners S.A. (ALNT) trades on the Madrid Exchange in Spain. It last closed at EUR 8.760 on 23 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 121 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.3% and over the last three months it fell 13.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.7% | ||
| From 52-week high | -20.4% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -13.7% | ||
| 6-month return | -15.0% | ||
| 12-month return, skipping the last month | 14.4% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 20.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.3% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.14M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 81 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.6% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.3% |
|---|---|
| 1 month | −6.2% |
| 3 months | −13.7% |
| 6 months | −15.0% |
| 1 year | +7.3% |
| 3 years | +4.4% |
| 5 years | −34.7% |
Signals
| 50-day / 200-day average | 9.507 / 9.595 |
|---|---|
| Golden / death cross (60 days) | Death, 3 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.163 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2026 | EUR 0.4050 |
| 8 May 2025 | EUR 0.1215 |
| 8 May 2024 | EUR 0.0648 |
| 10 May 2023 | EUR 0.4050 |
| 9 Nov 2022 | EUR 0.2592 |
| 11 May 2022 | EUR 0.4455 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.